Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 1997

View Archived Issues

Company Profile: CombiChem

Novel hypoglycemic thiazolidinedione derivative presented by Kyorin

Discovery of novel, orally active ACAT inhibitor, FR-186054, reported by Fujisawa

E-4010: highly potent and selective PDE V inhibitor from Eisai

Eisai develops novel retinoids as highly potent and selective RXR agonists

New FPP-based inhibitor of protein farnesyltransferase discovered at Banyu

Raloxifene clinical data supports therapeutic utility of novel SERM

Cangene to evaluate Leucotropin in phase III

Long-term asthma therapy options compared in children

Yamanouchi describes development of dual NK1/NK2 antagonist

Total synthesis of aglaiastatin C, a natural antitumor alkaloid

Pediatric rotavirus vaccine approval recommended

Cytoprotective effects of TTC-909 demonstrated in SHR-SP

OPC-14597: a novel D2 antagonist/DA autoreceptor agonist for schizophrenia

Gliatech's ADCON-L recommended for approval

Fujisawa describes preparation of new 5alpha-reductase inhibitor for BPH

Effects of F-1394 on cholesterol esterification/secretion in cultured human intestinal cells

Phase II results reported for Bexxar

TAP acquires North American rights to Meiact

Bupropion: drug of choice for depression in males with erectile dysfunction?

Mitsubishi Chemical expands R&D at home and abroad

Migranal Nasal Spray approved by FDA

Adenovirus-mediated delivery of human tissue kallikrein: novel gene therapy for hypertension

Somatogen: Q1 1998 highlights

Peptimmune acquires option for HIV vaccine-related technology from MGH

Atopy associated with IL-4R mutation; findings support Immunex's development of soluble IL-4R

Alteon and Genentech collaborate on diabetic complications therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...